Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer

The CHHiP trial investigated the use of moderate hypofractionation for the treatment of localised prostate cancer using intensity-modulated radiotherapy (IMRT). A radiotherapy quality assurance programme was developed to assess compliance with treatment protocol and to audit treatment planning and dosimetry of IMRT. This paper considers the outcome and effectiveness of the programme.

Source: Clinical Oncology - June 10, 2019 Category: Radiology Authors: O. Naismith, H. Mayles, M. Bidmead, C.H. Clark, S. Gulliford, S. Hassan, V. Khoo, K. Roberts, C. South, E. Hall, D. Dearnaley, the CHHiP Investigators Tags: Original Article Source Type: research